Home ›
Trademark Categories ›
Pharmaceuticals ›
2019 ›
RA ›
RANVYSO
Trademark search for:
RANVYSO
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-12-18 — Application filed
2020-02-13 — Sn assigned for sect 66a appl from ib
2020-02-14 — Application filed
2020-02-18 — Application filed
2020-03-02 — Assigned to examiner
2020-03-03 — Final disposition recorded
2020-03-04 — Office action issued
2020-03-24 — Office action issued
2020-03-24 — Office action issued
2020-04-10 — Office action issued
2020-05-22 — Limitation of goods received from ib
2020-07-27 — Attorney/dom.rep.revoked and/or appointed
2020-07-27 — Teas change of domestic representatives address
2020-07-27 — Teas change of owner address received
2020-07-27 — Teas change of correspondence received
2020-07-27 — Applicant/correspondence changes (non-responsive) entered
2020-07-27 — Teas revoke/app/change addr of atty/dom rep received
2020-09-18 — Teas/email correspondence entered
2020-09-18 — Office action issued
2020-09-18 — Correspondence received in law office
2020-09-23 — Office action issued
2020-09-23 — Office action issued
2020-09-23 — Office action issued
2020-10-20 — Limitation from the ib examined, no action is needed
2021-03-23 — Attorney/dom.rep.revoked and/or appointed
2021-03-23 — Teas change of domestic representatives address
2021-03-23 — Teas request for reconsideration received
2021-03-23 — Exparte appeal received at ttab
2021-03-23 — Jurisdiction restored to examining attorney
2021-03-23 — Teas change of correspondence received
2021-03-23 — Ex parte appeal-instituted
2021-03-23 — Teas revoke/app/change addr of atty/dom rep received
2021-03-26 — Approved for pub - principal register
2021-03-26 — Teas/email correspondence entered
2021-03-26 — Assigned to lie
2021-03-26 — Correspondence received in law office
2021-03-27 — Exparte appeal terminated
2021-04-14 — Notification of possible opposition sent to ib
2021-04-14 — Notification of notice of publication e-mailed
2021-04-14 — Notice of start of opposition period created, to be sent to ib
2021-05-02 — Notification processed by ib
2021-05-04 — Published for opposition
2021-05-04 — Official gazette publication confirmation e-mailed
2021-06-04 — New representative at ib received
2021-07-14 — Notification of possible opposition sent to ib
2021-07-14 — Notification of possible opposition created, to be sent to ib
2021-07-20 — Registered-principal register
2021-07-31 — Notification of possible opposition - processed by ib
2021-10-20 — Final disposition recorded
2021-11-26 — Final disposition recorded
2021-11-27 — Final disposition recorded
2021-12-19 — Final disposition recorded
2022-12-03 — Limitation of goods received from ib
2023-01-09 — Assigned to paralegal
2023-02-03 — Notification of effect of cancellation of intl reg e-mailed
2023-02-03 — Limitation from the ib examined and entered
2023-02-10 — Final status recorded
Owner Information
STADA Arzneimittel AG
DE
STADA Arzneimittel AG
DE
STADA Arzneimittel AG
DE
Correspondent
Philip R. Zender SQUIRE PATTON BOGGS (US) LLP 275 Battery Street, Suite 2600 San Francisco, CA 94111 UNITED STATES
Filing Details
Filing Date:
2019-12-18
Status Date:
2023-02-10
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.